View of Prevalence Of Hematological Side Effects Of Ribavirin Plus Pegylated Interferon Combination Therapy In Chronic Hepatitis C Treated Patients

Return to Article Details Prevalence Of Hematological Side Effects Of Ribavirin Plus Pegylated Interferon Combination Therapy In Chronic Hepatitis C Treated Patients Download Download PDF